R Squared’s GSK GSK Stock Holding History

R Squared’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275K	Buy	5,244 +1,088	+26%	+$57.5K	0.14%	251
2026 Q1	$229K	Sell	4,156 -1,669	-29%	-$90.4K	0.13%	277
2025 Q4	$286K	Buy	+5,825	New	+$272K	0.13%	245
2025 Q1	–	Sell	-5,170	Closed	-$175K	–	787
2024 Q4	$175K	Buy	+5,170	New	+$186K	0.17%	135

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

R Squared's GSK Position: Q2 2026 in Review

R Squared increased its GSK (GSK) stake by 26% in Q2 2026, buying an estimated $57.5K and bringing the position to 5,244 shares worth $275K. The position accounts for 0.14% of the portfolio, ranked #251.

R Squared first reported a position in GSK in Q4 2024 and has held it in 4 quarters since. The position peaked at $286K in Q4 2025. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

R Squared held 5,244 shares of GSK worth $275K as of Q2 2026.
R Squared bought 1,088 GSK shares in Q2 2026, an estimated $57.5K.
GSK made up 0.14% of R Squared's portfolio in Q2 2026, its #251 holding.
R Squared first reported a position in GSK in Q4 2024 and has held it in 4 quarters since.
R Squared's GSK position peaked at $286K in Q4 2025.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.